News

ISSAD is excited to announce that Dr Carol J. Baker will be taking part in moderating Track 1 at the ISSAD Conference in November. Formerly a professor of paediatrics, molecular virology and microbiology at Baylor College of Medicine (BCM) from 1975-2018. Dr Baker made groundbreaking recognition of neonatal and young infant group B streptococcal disease and its correlation of lack of maternal antibodies to the GBS capsular polysaccharide during her infectious diseases fellowship training at Read more…

ISSAD are excited to announce that the below speakers will be taking part in the keynote sessions at the ISSAD Conference in November. Dr Kate O’Brien will be taking part as a keynote speaker on the first day of the conference. In her role, she is responsible for leading WHO’s strategy and implementation to advance the vision of a world where everyone, everywhere, at every age, fully benefits from vaccines for good health and wellbeing. Read more…

Thank you for viewing our new ISSAD.org website, to optimise your experience to attend the ISSAD virtual conference on identifying and preventing morbidity and mortality caused by Streptococcus agalactiae. The hybrid conference takes place 3 – 5 November 2021. The conference will be fully virtual but with some in-person attendance at BMA House (depending on Covid-19 restrictions). Abstract submissions open on Monday 17th May 2021 and close on Monday 12th July 2021 midnight BST. Please Read more…